These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38272656)

  • 1. ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.
    Faggianelli F; Witjas T; Azulay JP; Benatru I; Hubsch C; Anheim M; Moreau C; Hainque E; Drapier S; Jarraya B; Laurencin C; Guehl D; Hopes L; Brefel-Courbon C; Tir M; Marques A; Rouaud T; Maltete D; Giordana C; Baumstarck K; Rascol O; Corvol JC; Rolland AS; Devos D; Eusebio A;
    J Neurol Neurosurg Psychiatry; 2024 Jun; 95(7):656-662. PubMed ID: 38272656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.
    Fabbri M; Coelho M; Guedes LC; Chendo I; Sousa C; Rosa MM; Abreu D; Costa N; Godinho C; Antonini A; Ferreira JJ
    Parkinsonism Relat Disord; 2017 Jun; 39():37-43. PubMed ID: 28389156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson's Disease.
    Rosqvist K; Odin P; Hagell P; Iwarsson S; Nilsson MH; Storch A
    J Parkinsons Dis; 2018; 8(3):409-420. PubMed ID: 30056433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.
    Lhommée E; Wojtecki L; Czernecki V; Witt K; Maier F; Tonder L; Timmermann L; Hälbig TD; Pineau F; Durif F; Witjas T; Pinsker M; Mehdorn M; Sixel-Döring F; Kupsch A; Krüger R; Elben S; Chabardès S; Thobois S; Brefel-Courbon C; Ory-Magne F; Regis JM; Maltête D; Sauvaget A; Rau J; Schnitzler A; Schüpbach M; Schade-Brittinger C; Deuschl G; Houeto JL; Krack P;
    Lancet Neurol; 2018 Mar; 17(3):223-231. PubMed ID: 29452685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
    J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson's disease.
    Mondillon L; Mermillod M; Musca SC; Rieu I; Vidal T; Chambres P; Auxiette C; Dalens H; Marie Coulangeon L; Jalenques I; Lemaire JJ; Ulla M; Derost P; Marques A; Durif F
    Neuropsychologia; 2012 Oct; 50(12):2869-2879. PubMed ID: 22944002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
    Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS;
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients.
    Brun L; Lefaucheur R; Fetter D; Derrey S; Borden A; Wallon D; Bourre B; Maltête D
    Clin Neurol Neurosurg; 2014 Dec; 127():93-6. PubMed ID: 25459250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: two-years' follow-up.
    Ortega-Cubero S; Clavero P; Irurzun C; Gonzalez-Redondo R; Guridi J; Obeso JA; Rodriguez-Oroz MC
    Parkinsonism Relat Disord; 2013 May; 19(5):543-7. PubMed ID: 23453890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heterogeneity of non-motor symptoms of Parkinson's disease.
    Zhang N; Liu W; Ye M; Cohen AD; Zhang Y
    Neurol Sci; 2015 Apr; 36(4):577-84. PubMed ID: 25376559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of subthalamic nucleus stimulation and levodopa on decision-making in Parkinson's disease.
    Atkinson-Clement C; Cavazzini É; Zénon A; Witjas T; Fluchère F; Azulay JP; Baunez C; Eusebio A
    Mov Disord; 2019 Mar; 34(3):377-385. PubMed ID: 30681186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of secondary unresponsiveness to dopaminergic drugs with preserved response to subthalamic nucleus stimulation in Parkinson's disease.
    Lenka A; Jhunjhunwala KR; Stezin A; Manjunath M; Srinivas D; Yadav R; Pal PK
    Neurol India; 2018; 66(Supplement):S135-S137. PubMed ID: 29503336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.